Bayer partnered with Population Health Research Institute on global clinical research evaluating COVID-19 treatments
On Apr. 21, 2020, Bayer Mississauga, Ontario announced a partnership with the Population Health Research Institute (PHRI) to…
Expert US panel developed NIH treatment guidelines for COVID-19
On Apr. 21, 2020, A panel of U.S. physicians, statisticians, and other experts developed treatment guidelines for coronavirus…
National Science Foundation awarded rapid response grants to support coronavirus (COVID-19) research
On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…
VA researchers announced study of COVID-19 in aging Veterans with dementia
On Apr. 21, 2020, researchers at the U.S. Department of Veterans Affairs’ (VA) Providence VA Medical Center began…
Hydroxychloroquine study reported no benefit from malaria drug in Veteran Affairs virus study
On Apr. 21, 2020, a study posted on medRxiv found no evidence that use of hydroxychloroquine, either with…
Vaxart announced positive preclinical data for ioral COVID-19 vaccine program
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
aTyr Pharma announced phase 2 study of ATYR1923 in COVID-19 patients with severe respiratory complications
On Apr. 21, 2020, aTyr Pharma announced the FDA has accepted its Investigational New Drug application to evaluate…
ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trials
On Apr. 21, 2020, BioSig Technologies announced that subsidiary ViralClear Pharmaceuticals, had submitted an application for Vicromax(tm) (merimepodib,…
Tyson Fresh Meats resumed limited operations at Columbus Junction Pork Plant
On Apr. 21, 2020, Tyson Fresh Meats resumed limited operations at its pork plant in Columbus Junction, Iowa,…
OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patients
On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…
LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization
On Apr. 21, 2020, LabCorpï¾® announced it has received an Emergency Use Authorization (EUA) from the FDA. The…
Quest Diagnostics began performing COVID-19 antibody testing
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…
More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering study
On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…
New virus detection process under development at Rutgers-Camden
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers Universityï¾–Camden research laboratory, where chemistry…
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics
Todos Medical announced FDA Emergency Use Authorization allowed for Gnomegen COVID-19 PCR test kits
On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for…
Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…
Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needs
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus
On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…
Biotechnology | COVID-19 | Disease | FDA | Life Science News | Therapeutics
Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients
On Apr. 20, 2020, Novartis has reached an agreement with the FDA to proceed with a Phase III…
USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County
On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…
Oxford University project assessed Coronavirus infection rates in children and teenagers across UK
On Apr. 20, 2020, a multi-site project, called ‘What’s the STORY?’ received funding from UK Research and Innovation…
Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
Alexion announced plans to initiate phase 3 study of ULTOMIRISï¾® (ravulizumab-cwvz) in hospitalized patients with severe COVID-19
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISï¾® (ravulizumab-cwvz)…
Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
IDEXX made pet test for COVID-19 Virus available to veterinarians
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
Rice University COVID-19 research fund awarded first grants
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
CDC | COVID-19 | Life Science History | NIH
The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
Antiviral remdesivir prevented disease progression in monkeys with COVID-19
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
Five Oxford University COVID-19 projects received UK Research and Innovation funding
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…